Monkeypox cases are increasing rapidly in New York, primarily among social networks of homosexual and bisexual men, officials say.
“Cases are increasing in NYC,” the Health Department said, adding that there are likely to be more cases that haven’t yet been diagnosed.
“Most of these people have not been hospitalized and have recovered on their own,” officials stated.
The Health Department said that New York City, which is the epicenter of the monkeypox outbreak in the United States, has a limited supply of vaccine doses.
“Given the rapid increase in cases, the Health Department has decided that providing first doses to offer protection to more at-risk New Yorkers is the best strategy until we receive adequate vaccine supply,” officials said, noting that the single-dose strategy is in line with the distribution of monkeypox vaccines in the UK and Canada.
Monkeypox is a rare virus believed to be transmitted to humans from animals and, before this year, was endemic to Central and West Africa. It can spread from one person to another through close contact with bodily fluids, lesions, respiratory droplets, or contaminated materials.
Vaccine Doses Arrive in New York
According to a chart posted on July 15 by Manhattan Borough President Mark D. Levine, 95.5 percent of cases between July 1 and 13 were among men and 60 percent of the cases were attributed to homosexual males and LGBT people.“New York State and New York City have already received more than 28,000 doses to date, and ... will now receive another 32,785 vaccine doses next week to continue our efforts in responding to and meeting the needs of our most at-risk populations,” she said.
However, Mayor Eric Adams, pointing to New York City’s surge in cases, said more vaccines are needed to combat spread of the virus.
“We have 25 percent of the cases; this is ground zero, this is the epicenter,” he said. “We had great communication with the White House. ... We’re hoping that they’re going to hear us and bring in the numbers that we need.”
The latest order of vaccines announced on July 15 will begin arriving in the Strategic National Stockpile in 2023, “bringing the federal government’s available supply of vaccine to treat monkeypox to nearly 7 million doses by mid-2023,” according to the HHS.